These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5810119)

  • 1. [Analogs of prenylamine].
    Collino F
    Boll Chim Farm; 1969 Jun; 108(6):355-67. PubMed ID: 5810119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sympatholytic ("antisympathotonic") substances].
    Kruger K
    Minerva Med; 1968 Dec; 59(96):5227-30. PubMed ID: 5710726
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of diphenylalkyl derivatives. I. Comparative studies of coronary dilator diphenylalkylamine derivatives.
    Leszkovszky G; Tardos L; Erdély I; Harsányi K
    Acta Physiol Acad Sci Hung; 1966; 29(3):283-97. PubMed ID: 5923039
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficiency of human cardiac action by coronary dilators].
    Schirmer R; Hamacher J
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):440. PubMed ID: 4253863
    [No Abstract]   [Full Text] [Related]  

  • 6. [The coronary dilatator effect of various reference drugs].
    Duchene-Marullaz P; Cosnier D; Grimald J
    Therapie; 1969; 24(4):617-20. PubMed ID: 5821999
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and pharmacological study of diphenylalkylamines with cycloaliphatic residues. New coronary vasodilators.
    Carenini G; Carissimi M; Gentili PG; Grumelli E; Piccióla G; Ravenna F
    Arzneimittelforschung; 1976; 26(12):2127-36. PubMed ID: 1037261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mode of action of prenylamine (Segontin) and other coronary dilating drugs in man.
    Schmid E; Bachmann K; Krautheim J; Heynen HP
    Indian Heart J; 1968 Apr; 20(2):133-40. PubMed ID: 5738423
    [No Abstract]   [Full Text] [Related]  

  • 9. [The formation of collaterals in the coronary vascular system of the dog. Experimental proof of the collateral formation in the dog heart following prenylamine-lactate treatment].
    Starey F
    Arzneimittelforschung; 1972 Aug; 22(8):1317-20. PubMed ID: 4678393
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of the coronary effect of oxyfedrin].
    Bayer BL; Mentz P; Förster W
    Acta Biol Med Ger; 1972; 28(6):1085-7. PubMed ID: 4674026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the mechanism of action of prenylamine].
    Lindner E
    Arzneimittelforschung; 1969 Jan; 19(1):15-9. PubMed ID: 5819360
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical aspects of persantin, segontin and trimanyl in the light of the results of experimental studies on the coronary circulation in dogs].
    Janicki K; Wcislo W
    Pol Tyg Lek; 1967 May; 22(21):779-81. PubMed ID: 6040998
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of odiphalin and difril on catecholamine concentration in adrenergic nerve fibers of different rat organs].
    Strinskaia LA; Leont'eva GR; Avakian OM; Govyrin VA
    Biull Eksp Biol Med; 1980 Dec; 90(12):698-700. PubMed ID: 7470606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
    DELLA PORTA P; LUCCHINI CR
    Minerva Cardioangiol; 1961 Sep; 9():533-6. PubMed ID: 13885183
    [No Abstract]   [Full Text] [Related]  

  • 15. Recently introduced cardiovascular drugs under experimental test.
    KOHLER H
    Drugs Made Ger; 1963 Jun; 6():71-2. PubMed ID: 14034203
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical observations on the use of a new synthetic agent (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine, Segontin) in coronary insufficiency syndromes].
    CESARI L
    Gazz Int Med Chir; 1962 Sep; 66():1994-2004. PubMed ID: 14019763
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].
    Fleckenstein A; Tritthart H; Flackenstein B; Herbst A; Grün G
    Pflugers Arch; 1969; 307(2):R25. PubMed ID: 5814829
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reversible blockade of excitation-contraction coupling in rat's uterine smooth muscle by means of organic calcium antagonists (iproveratril, D 600, prenylamine)].
    Fleckenstein A; Grün G
    Pflugers Arch; 1969; 307(2):R26. PubMed ID: 5814830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analogy of the effects of N-(1-methyl-2-phenylethyl)-1, 1-diphenyl-3-propylamine (Segontin) and reserpine on arterial pressure].
    SCHMITT H; SCHMITT H
    C R Seances Soc Biol Fil; 1962; 156():440-2. PubMed ID: 13908832
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the site of action of persantin, segontin and trimanyl. Their effect on the bioelectric activity of rabbit's brain.
    Janicki K; Trabka J; Gatarski J
    Pol Med J; 1970; 9(1):1816. PubMed ID: 5437035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.